AnaptysBio
ANAB
ANAB
124 hedge funds and large institutions have $1.77B invested in AnaptysBio in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 61 increasing their positions, 33 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
-10
Holders Change %
-7.46%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.07%
New
20
Increased
61
Reduced
33
Closed
29
Calls
$6.74M
Puts
$15.8M
Net Calls
-$9.1M
Net Calls Change
+$4.34M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$62.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$37.7M |
| 3 |
State Street
Boston,
Massachusetts
|
+$24.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.6M |
Top Sellers
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$97.5M |
| 2 |
PA
Perceptive Advisors
New York
|
-$24.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$21.7M |
| 4 |
VMI
VHCP Management II
New York
|
-$18.8M |
| 5 |
DM
Deerfield Management
New York
|
-$16.4M |
